BioConst生物常量

Research reference only. BioConst updates and corrects content over time, but it cannot replace clinician-guided diagnosis, treatment, medication, or testing decisions.

Liver

Cholestasis, bilirubin, and bile flow

Reduced bile flow or bilirubin handling can make jaundice and liver-panel interpretation more complex.

Clinician-guided interpretation page

This topic can involve test or imaging interpretation, neurological, cardiac, blood, liver, kidney, lung, surgical, medication, or complex underlying-disease context. BioConst keeps this page as an explainer, not a decision guide.

What this means

Cholestasis context means bile flow or bilirubin handling may be reduced or blocked.[1,2]

What people may notice

  • Bilirubin and liver-panel patterns can frame jaundice and bile-flow questions.[1,2]
  • Alkaline phosphatase can enter liver or bile-duct pattern discussion.[1,2]

Key variables

Bile flow and cholestasis

Bile-flow context is the organizing variable.[1,2]

Bilirubin

Bilirubin connects bile handling to jaundice context.[1,2]

Alkaline phosphatase in liver context

ALP can support a bile-flow pattern when interpreted in context.[1,2]

Why it happens

  • Bile flow can be affected by liver-cell, bile-duct, gallbladder, medication, or obstruction context.[1,2]
  • Imaging and pattern review may be needed to separate causes.[1,2]

Clinical response directions

  • Clinical teams may use history, exam, labs, imaging, and specialist review depending on bile-flow and bilirubin context.[1,2]
  • BioConst explains the map and does not diagnose, rank urgency, choose tests, or recommend treatment.[1,2]

Common traps

  • Jaundice context is not identical to cirrhosis.[1,2]
  • ALP is not liver-only because bone context can matter.[1,2]
  • One bilirubin value does not identify the site of blockage.[1,2]

Related wiki variables